Showing results (281-290 of 358) with videos related to

Sort By:
Pageof 36
Nature Communications|November 2, 2021
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypesBrian D Lehmann, Antonio Colaprico, Tiago C Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2018
Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER<sup>+</sup>/HER2<sup>+</sup> Breast Cancers: Implications to the ExteNET TrialDhivya R Sudhan, Luis J Schwarz, Angel Guerrero-Zotano, et al.
Research Square|July 17, 2025
Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancerJustin Balko, Xiaopeng Sun, Ann Hanna, et al.
The Journal of Clinical Investigation|September 4, 2013
ErbB3 downregulation enhances luminal breast tumor response to antiestrogensMeghan M Morrison, Katherine Hutchinson, Michelle M Williams, et al.
NPJ Breast Cancer|May 16, 2018
Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancerDaniel G Stover, Carlos R Gil Del Alcazar, Jane Brock, et al.
Circulation|January 7, 2026
CXCR6<sup>+</sup> T Cells Drive Immune Checkpoint Inhibitor MyocarditisAmir Z Munir, Alan Gutierrez, Cade J Krawiec, et al.
The Journal of Clinical Investigation|November 18, 2014
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancerLuis J Schwarz, Emily M Fox, Justin M Balko, et al.
NPJ Breast Cancer|November 9, 2019
If we build it they will come: targeting the immune response to breast cancerMargaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, et al.
Cancers|April 27, 2024
EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast CancerAnn M Chan, Brian Aguirre, Lucia Liu, et al.
Cancer Immunology Research|January 13, 2025
In Situ Detection of Individual Classic MHC-I Gene Products in CancerPaula I Gonzalez-Ericsson, Susan R Opalenik, Violeta Sanchez, et al.
Pageof 36